Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Summer 2016 - Vaccines
Download Issue
Share
Up Front
Publisher's Corner
Despite Vaccine Benefits, Challenges Persist
By Patrick M. Schmidt
Features
Vaccines for International Travel
By
Bob Geng, MD, MA
Influenza Vaccination: What’s New with the Flu?
By
Trudie Mitschang
Evolving Technology in Vaccine Administration
By
Diane L.M. Cook
Influenza Vaccine: A Universal Game Changer?
By
Ronale Tucker Rhodes, MS
Myths vs. Facts: Bacterial Skin Infections
By
Ronale Tucker Rhodes, MS
BioTrends Watch
Washington Report
CMS to Implement New Primary Care Payment Model
CMS Issues Final Rule for DMEPOS
CMS Finalizes 2017 ACA Marketplace Plan Requirements
Medicare Rights Launches New Medicare Interactive
CMS to Reimburse ICD-10 Mistakes for One Year
Reimbursement FAQs
New Part B Drug Payment Models
Industry News
Empliciti Approved by FDA to Treat Multiple Myeloma
Study Provides Clues for Improving Effectiveness of Flu Vaccine
CDC Issues Guidelines for Prescribing Opioids for Chronic Pain
Flu Vaccine Given in the Morning Could Be More Effective
FDA Approves First Coagulation Factor-Albumin Fusion Protein to Treat Hemophilia B
Genome Sequencing Uncovers New Autoimmune Syndrome
Phase I Trial Launched for Extended Half-Life Factor VIII
Key Genetic Factor Behind Autoimmune Diseases and Cancer Is Identified
Potential Tobacco-Based Vaccine Could Rival Egg-Based Vaccines
Scientists Find a Potential Cure for Cancer
Second Biosimilar Drug in U.S. Is Approved by FDA
FDA Expands Approval of Combination Therapy for Melanoma
Malaria Vaccine Candidate Generates Robust Immune Response
BioFocus
Industry Insight
Childhood Vaccine Refulsal: The Bad Outcomes of Good Intentions
By Keith Berman, MPH, MBA
Patient Profile
Multiple Sclerosis: A Patient’s Perspective
By Trudie Mitschang
Patient Advocacy: A Patient's Perspective
By Trudie Mitschang
Physician Profile
Patient Advocacy: A Professional's Perspective
By Trudie Mitschang
Disease Profile
Update on Polio and Post-Polio Syndrome
By Jim Trageser
BioSources
BioResearch
Gene Therapy Results in Sustained Factor VIII Expression and Reduced Bleeding Episodes in Dogs with Severe Hemophilia A
Meta-Analysis Reveals No Evidence that IVIG Administration Increases Risk of Thromboembolic Events